Wenqing Liang Selected Research

aspartic proteinase A

1/2016

[Distant metastases to maxillary sinus from an unknown lung adenocarcinoma: a cases report].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenqing Liang Research Topics

Disease

16	Neoplasms (Cancer) 12/2022 - 06/2012
9	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 01/2013
2	Wounds and Injuries (Trauma) 05/2021 - 08/2019
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2021 - 07/2013
2	Spinal Cord Injuries (Spinal Cord Injury) 08/2019 - 01/2019
1	Bone Neoplasms (Bone Cancer) 12/2022
1	Liver Neoplasms (Liver Cancer) 12/2022
1	Bone Fractures (Bone Fracture) 01/2022
1	Digestive System Neoplasms (Cancer of the Digestive System) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Melanoma (Melanoma, Malignant) 12/2021
1	Microsatellite Instability 12/2021
1	Colorectal Neoplasms (Colorectal Cancer) 12/2021
1	Stomach Neoplasms (Stomach Cancer) 07/2021
1	Insulin Resistance 01/2021
1	Carcinogenesis 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2019
1	Neoplasm Metastasis (Metastasis) 11/2019
1	Disease Progression 11/2019
1	Atherosclerotic Plaque (Atheroma) 02/2018
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2018
1	Adenocarcinoma of Lung 01/2016
1	Cicatrix (Scar) 01/2015
1	Knee Osteoarthritis 12/2014
1	Dyslipidemias (Dyslipidemia) 03/2013
1	Sarcoma (Soft Tissue Sarcoma) 01/2013
1	Hepatitis B 01/2013
1	Multiple Myeloma 06/2012

Drug/Important Bio-Agent (IBA)

5	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2013
4	Long Noncoding RNAIBA 01/2022 - 01/2018
3	CytokinesIBA 01/2022 - 01/2021
3	Small Interfering RNA (siRNA)IBA 12/2015 - 06/2012
2	Pharmaceutical PreparationsIBA 12/2022 - 01/2022
2	HydrogelsIBA 12/2022 - 12/2022
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2015
2	CateninsIBA 01/2022 - 06/2012
2	Caspase 3 (Caspase-3)IBA 08/2019 - 06/2012
1	Oxygen (Dioxygen)IBA 08/2022
1	carvacrolIBA 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	Sincalide FDA Link 01/2022
1	Circular RNAIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	pembrolizumabIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Immune Checkpoint InhibitorsIBA 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	NivolumabIBA 12/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2021
1	AntibodiesIBA 07/2021
1	Insulin (Novolin)FDA Link 01/2021
1	AndrogensIBA 01/2021
1	NucleotidesIBA 12/2020
1	PhosphoproteinsIBA 11/2019
1	Matrix Metalloproteinases (MMPs)IBA 11/2019
1	LipopolysaccharidesIBA 08/2019
1	Interleukin-6 (Interleukin 6)IBA 08/2019
1	Keratin-5 (Keratin 5)IBA 01/2019
1	Keratins (Keratin)IBA 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	VimentinIBA 01/2019
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2019
1	DesminIBA 01/2019
1	MyoglobinIBA 01/2019
1	palomid 529IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	Biological ProductsIBA 01/2017
1	aspartic proteinase AIBA 01/2016
1	Chemotactic FactorsIBA 12/2015
1	Proteins (Proteins, Gene)FDA Link 12/2015
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2015
1	Bone Morphogenetic Protein 5IBA 12/2014
1	AminopeptidasesIBA 12/2014
1	Androgen Receptors (Androgen Receptor)IBA 07/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2013
1	fenofibric acid FDA Link 03/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	DNA VaccinesIBA 01/2013
1	Hemostatics (Antihemorrhagics)IBA 06/2012

Therapy/Procedure

6	Therapeutics 12/2022 - 03/2013
3	Drug Therapy (Chemotherapy) 12/2022 - 12/2020
1	Radiotherapy 01/2022
1	Immunotherapy 12/2021
1	Intraperitoneal Injections 01/2018
1	Cutaneous Administration 01/2013